Global Mofy AI Limited (NASDAQ: GMM) and HAOXI Health Technology Limited (NASDAQ: HAO) entered into a three‑year strategic cooperation agreement on March 3 2026. The partnership, executed through GMM’s U.S. subsidiary Eaglepoint AI Inc., will focus on joint research and development, data sharing, and the use of HAOXI’s distribution network to promote GMM’s generative‑AI‑driven virtual content solutions within the health‑technology market.
The deal gives GMM access to HAOXI’s extensive data sets and marketing channels, enabling the company to tailor its Mofy Lab platform for medical imaging, patient education, and digital health applications. In return, HAOXI will leverage GMM’s high‑definition virtual asset capabilities to accelerate the time‑to‑market for AI‑enabled health solutions, including an upcoming AI Digital Health Manager SaaS targeting sub‑health and chronic‑disease populations.
For GMM, the partnership marks a strategic shift beyond entertainment and advertising into the growing digital health sector. FY2025 revenue of $56 million grew 35.3% year‑over‑year, but the company posted a GAAP net loss of $19.3 million and an operating margin of 5.4%. The partnership offers a new revenue stream that could help offset the loss and improve profitability as the company applies its AI‑native workflow to health‑tech use cases.
HAOXI, which reported FY2025 revenue of $33 million and a gross margin of 2.8%, has faced a 32.4% decline in sales and an operating loss of 6.1%. The collaboration provides HAOXI with advanced AI content tools that can enhance its existing online‑marketing solutions for healthcare clients, potentially improving margins and diversifying its product mix.
Eaglepoint AI’s Aquila engine, a multimodal model‑evaluation platform, will be deployed to validate large‑language models for clinical applications. Combined with HAOXI’s data‑governance expertise and marketing network, the partnership is positioned to accelerate the development of AI‑driven preventive‑health tools, addressing a market demand for personalized, quantifiable health management solutions.
"The company has long served domestic and international healthcare clients, managing tens of billions of online advertising data points. We understand clients' urgent demand for personalized, quantifiable health management solutions," said Fan Zhen, CEO of HAOXI. The quote underscores the strategic fit of the partnership and the headwinds HAOXI faces in a low‑margin environment, while highlighting the opportunity to capture a growing health‑tech market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.